K. Ruxrungtham

发表

Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial

Michelle Le Braz, H. Furrer, B. Hirschel, 2003, AIDS.

Comprehensive serological profiling of human populations using a synthetic human virome

S. Elledge, B. Walker, T. Ndung’u, 2015, Science.

Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network.

K. Ruxrungtham, G. Suwanpimolkul, K. Kawkitinarong, 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent

D. Podzamczer, K. Ruxrungtham, D. Haas, 2011, AIDS.

Highly Active Antiretroviral Therapy (HAART) Retreatment in Patients on CD4-Guided Therapy Achieved Similar Virologic Suppression Compared With Patients on Continuous HAART: The HIV Netherlands Australia Thailand Research Collaboration 001.4 Study

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2005, Journal of acquired immune deficiency syndromes.

UV Treatment Nucleic Acid Probe Without Biotin-Labeling Is Sensitive and Sufficient For The Fabrication of Nucleic Acid Lateral Flow (NALF) Strip Test

K. Ruxrungtham, A. Sereemaspun, M. Pongsuchart, 2013 .

Sensitivity enhancement of nucleic acid detection by lateral flow strip test using UV crosslink method

K. Ruxrungtham, A. Sereemaspun, M. Pongsuchart, 2012 .

A low cost duplex polymerase chain reaction to detect common HIV-1 CRF 01AE reverse transcriptase inhibitors resistance-associated mutations: 103N/181C and 151M/ 215Y

K. Ruxrungtham, S. Sirivichayakul, C. Ketloy, 2009 .

Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients.

K. Ruxrungtham, A. Avihingsanon, B. Punyawudho, 2017, International journal of antimicrobial agents.

Lack of Enzyme‐Inducing Effect of Rifampicin on the Pharmacokinetics of Enfuvirtide

K. Ruxrungtham, I. Patel, K. Nieforth, 2003, Journal of clinical pharmacology.

Safety and immunogenicity of Bacillus Calmette-Guerin vaccine in children born to HIV-1 infected women.

K. Ruxrungtham, U. Thisyakorn, P. Thaithumyanon, 2000, The Southeast Asian journal of tropical medicine and public health.

Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH S

R. Kaiser, J. Gatell, K. Ruxrungtham, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2003, AIDS.

Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations

K. Ruxrungtham, A. Thitithanyanont, W. Phoolcharoen, 2021, Vaccines.

Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients

K. Ruxrungtham, A. Birnbaum, T. Bunupuradah, 2021, Expert review of clinical pharmacology.

Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients.

K. Ruxrungtham, S. Emery, T. Bunupuradah, 2019, Pharmacogenomics.

Correlation of Selenium and Zinc Levels to Antiretroviral Treatment Outcomes in Thai HIV-infected Children without Severe HIV Symptoms

J. Ananworanich, K. Ruxrungtham, S. Kerr, 2012, European Journal of Clinical Nutrition.

CHAPTER 50 – HIV Transmission and its Prevention in Asia

K. Ruxrungtham, S. Kerr, 2008 .

Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz.

K. Ruxrungtham, D. Cooper, P. Reiss, 2006, The Journal of infectious diseases.

Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96‐week outcomes of HIV‐NAT 009

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2005, HIV medicine.

DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice

K. Ruxrungtham, T. Palaga, W. Wijagkanalan, 2021, PloS one.

DNA Vaccine Administered by Cationic Lipoplexes or by In Vivo Electroporation Induces Comparable Antibody Responses against SARS-CoV-2 in Mice

K. Ruxrungtham, S. Sirivichayakul, G. Borchard, 2021, Vaccines.

Anaphylaxis: a ten years inpatient retrospective study.

K. Ruxrungtham, W. Cheungpasitporn, Krittapoom Akrawinthawong, 2010, Asian Pacific journal of allergy and immunology.

Jackfruit anaphylaxis in a latex allergic patient.

K. Ruxrungtham, J. Klaewsongkram, S. Wongrakpanich, 2015, Asian Pacific journal of allergy and immunology.

Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial

G. Bloomfield, C. Fichtenbaum, K. Ruxrungtham, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical characteristics and treatment outcomes among patients with tuberculosis in Bangkok and Nonthaburi, Thailand.

K. Ruxrungtham, S. Akksilp, G. Suwanpimolkul, 2012, The Southeast Asian journal of tropical medicine and public health.

The 16th Bangkok International Symposium on HIV Medicine

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2013 .

Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapy.

K. Ruxrungtham, S. Kerr, Supalak Phonphithak, 2015, AIDS research and human retroviruses.

No change in calculated creatinine clearance after tenofovir initiation among Thai patients.

Michelle Le Braz, B. Hirschel, J. Ananworanich, 2007, The Journal of antimicrobial chemotherapy.

Higher proportion of abnormal nutritional status among well suppressed HIV-infected elderly Asians compared to HIV-negative individuals.

K. Ruxrungtham, S. Kerr, Lalita Wattanachanya, 2020, AIDS research and human retroviruses.

Rapid antiretroviral initiation among Thai youth living with HIV in the National AIDS programme in the era of treatment at any CD4 cell count: a national registry database study

K. Ruxrungtham, S. Kerr, T. Puthanakit, 2020, Journal of the International AIDS Society.

Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study

K. Ruxrungtham, D. Scherrer, H. Ehrlich, 2017, Antimicrobial Agents and Chemotherapy.

The immunomodulatory nutritional intervention NR100157 reduced CD4+ T-cell decline and immune activation: a 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study).

B. Gazzard, K. Ruxrungtham, M. Clerici, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

decline and immune activation: a one year multicentre randomised controlled doubleblind trial in HIVinfected subjects not receiving antiretroviral therapy (the BITE study)

B. Gazzard, K. Ruxrungtham, P. Cahn, 2013 .

Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial.

R. Davey, H. Lane, K. Ruxrungtham, 2019, Clinical Infectious Diseases.

High Prevalence of Lipid Abnormalities among Antiretroviral-Naive HIV-Infected Asian Children with Mild-To-Moderate Immunosuppression

J. Ananworanich, K. Ruxrungtham, T. Puthanakit, 2011, Antiviral therapy.

CD4 CELL COUNT CRITERIA TO DETERMINE WHEN TO INITIATE ANTIRETROVIRAL THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN

J. Ananworanich, K. Ruxrungtham, S. Kerr, 2010, The Pediatric infectious disease journal.

Short communication: Aging not gender is associated with high atazanavir plasma concentrations in Asian HIV-infected patients.

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2013, AIDS research and human retroviruses.

Poor quality of life among untreated Thai and Cambodian children without severe HIV symptoms

J. Ananworanich, K. Ruxrungtham, S. Kerr, 2012, AIDS care.

Prevalence of Human Leukocyte Antigen-B*5701 Among HIV-infected Children in Thailand and Cambodia: Implications for Abacavir Use

J. Ananworanich, K. Ruxrungtham, T. Puthanakit, 2012, The Pediatric infectious disease journal.

Public Health Interventions Research Group Publications, last ten years 2012

J. Kaldor, J. Ananworanich, K. Ruxrungtham, 2012 .

Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand

S. Vermund, J. Ananworanich, K. Ruxrungtham, 2009, Sexually Transmitted Infections.

Comparable carotid intima-media thickness among long-term virologically suppressed individuals with HIV and those without HIV in Thailand

K. Ruxrungtham, S. Kerr, A. Chutinet, 2019, Journal of virus eradication.

The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity.

K. Ruxrungtham, D. Cooper, P. Reiss, 2006, The Journal of antimicrobial chemotherapy.

Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial.

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2016, The lancet. HIV.

Role of Rilpivirine and Etravirine in Efavirenz and Nevirapine-Based Regimens Failure in a Resource-Limited Country: A Cross- Sectional Study

K. Ruxrungtham, S. Sirivichayakul, P. Ohata, 2016, PloS one.

Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure

K. Ruxrungtham, W. Prasithsirikul, W. Manosuthi, 2009, AIDS research and therapy.

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

S. Lewin, K. Ruxrungtham, D. Cooper, 2008, Hepatology.

Lack of Interaction between Enfuvirtide and Ritonavir or Ritonavir‐Boosted Saquinavir in HIV‐1‐Infected Patients

K. Ruxrungtham, I. Patel, M. Boyd, 2004, Journal of clinical pharmacology.

Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results

A. Vibhagool, K. Ruxrungtham, S. Rattanasiri, 2006, AIDS.

Performance of a simple flow cytometric assay in diagnosing active tuberculosis.

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2020, Tuberculosis.

Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2005, AIDS.

Efficacy of tenofovir disoproxil fumarate/ emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV–HBV coinfection in Thailand

S. Lewin, K. Ruxrungtham, S. Kerr, 2010, Antiviral therapy.

High‐dose bee venom exposure induces similar tolerogenic B‐cell responses in allergic patients and healthy beekeepers

K. Ruxrungtham, M. Sokolowska, A. Eljaszewicz, 2017, Allergy. European Journal of Allergy and Clinical Immunology.

Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age.

R. Gelman, J. Ananworanich, K. Ruxrungtham, 2010, The Journal of allergy and clinical immunology.

Effect of Solid Lipid Nanoparticles Formulation Compositions on Their Size, Zeta Potential and Potential for In Vitro pHIS-HIV-Hugag Transfection

K. Ruxrungtham, S. Sirivichayakul, U. Ruktanonchai, 2007, Pharmaceutical Research.

Intrapartum and neonatal zidovudine treatment in reduction of perinatal HIV-1 transmission in Bangkok.

K. Ruxrungtham, P. Phanuphak, U. Thisyakorn, 2001, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Toward improved evaluation of cytotoxic T-lymphocyte (CTL)-inducing HIV vaccines in Thailand.

K. Ruxrungtham, K. Ariyoshi, R. Sutthent, 2002, AIDS research and human retroviruses.

The Association of Gender, Age, Efavirenz Use, and Hypovitaminosis D Among HIV-Infected Adults Living in the Tropics.

K. Ruxrungtham, S. Kerr, Y. Avihingsanon, 2016, AIDS research and human retroviruses.

The House Dust Mite Major Allergen Der p 23 Displays O-Glycan-Independent IgE Reactivities but No Chitin-Binding Activity

K. Ruxrungtham, P. Chatchatee, T. Rerkpattanapipat, 2016, International Archives of Allergy and Immunology.

Exploring the Role of Serology Testing to Strengthen Vaccination Initiatives and Policies for COVID-19 in Asia Pacific Countries and Territories: A Discussion Paper

K. Ruxrungtham, P. Lee, T. Chotpitayasunondh, 2022, International Journal of Translational Medicine.

Efficacy of Second-Line Antiretroviral Therapy Among People Living With HIV/AIDS in Asia: Results From the TREAT Asia HIV Observational Database

K. Ruxrungtham, Viet-An Nguyen, M. Law, 2015, Journal of acquired immune deficiency syndromes.

Role of Der p 1–specific B cells in immune tolerance during 2 years of house dust mite–specific immunotherapy

C. Akdis, K. Ruxrungtham, S. Sirivichayakul, 2019, The Journal of allergy and clinical immunology.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Prevalence of CCR2-64I, SDF1-3'A and CCR5-Delta32 alleles in healthy Thais.

K. Ruxrungtham, P. Phanuphak, P. Phanuphak, 2000, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand

S. Lewin, K. Ruxrungtham, D. Cooper, 2012, AIDS Research and Therapy.

A two-step non-flowcytometry-based naïve B cell isolation method and its application in Staphylococcal enterotoxin B (SEB) presentation.

C. Nguyen, K. Ruxrungtham, A. Jacquet, 2012, Asian Pacific journal of allergy and immunology.

Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial

K. Ruxrungtham, E. Katabira, D. Steyn, 2010, AIDS.

Comparative Study of Patients in Correct Usage of and Preference for the Swinghaler and Turbuhaler Multidose Inhalers

K. Ruxrungtham, C. Bai, B. Margono, 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

Immunogenicity and Protective Efficacy of a SARS-CoV-2 mRNA Vaccine Encoding Secreted Non-Stabilized Spike Protein in Mice

D. Weissman, K. Ruxrungtham, J. Heyes, 2022, bioRxiv.

Human immunodeficiency virus and acquired immune deficiency syndrome in Asia: an update

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2017 .

Smoking and projected cardiovascular risk in an HIV‐positive Asian regional cohort

K. Ruxrungtham, S. Oka, M. Law, 2016, HIV medicine.

Production and immunogenicity of hypoallergenic codon-optimized DNA vaccine encoding mature Der p 1 allergen.

K. Ruxrungtham, S. Sirivichayakul, K. Okuda, 2010, Journal of investigational allergology & clinical immunology.

Bronchial hyperresponsiveness in HIV patients with CD4 count less than 500 cells/μL

K. Ruxrungtham, K. Kawkitinarong, C. Sittipunt, 2010 .

Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy.

S. Lewin, K. Ruxrungtham, G. Dore, 2014, The Journal of infectious diseases.

The values of nasal provocation test and basophil activation test in the different patterns of ASA/NSAID hypersensitivity.

K. Ruxrungtham, J. Klaewsongkram, S. Buranapraditkun, 2012, Allergologia et immunopathologia.

Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients

K. Ruxrungtham, D. Cooper, R. Autar, 2007, AIDS.

Relationships between Drug Exposure, Changes in Metabolic Parameters and Body Fat in HIV-Infected Patients Switched to a Nucleoside Sparing Regimen

K. Ruxrungtham, D. Cooper, P. Reiss, 2007, Antiviral therapy.

Cardiovascular risk assessment in persons with HIV in the developing world: comparing three risk equations in a cohort of HIV-infected Thais

K. Ruxrungtham, P. Phanuphak, J. Ananworanich, 2010, Journal of the International AIDS Society.

Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells

Hongjun Bai, D. Douek, J. Ananworanich, 2022, EBioMedicine.

Depression and anxiety were low amongst virally suppressed, long-term treated HIV-infected individuals enrolled in a public sector antiretroviral program in Thailand*

J. Ananworanich, K. Ruxrungtham, S. Kerr, 2017, AIDS care.

Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit Vaccine

K. Ruxrungtham, Kanitha Patarakul, T. Courant, 2022, Frontiers in Cellular and Infection Microbiology.

Inpatient asthma mortality in a tertiary referral hospital from 2000 to 2010.

K. Ruxrungtham, J. Klaewsongkram, H. Chantaphakul, 2012, Asian Pacific journal of allergy and immunology.

Incidence and risk factors of ischemic stroke and transient ischemic attack among people living with HIV: a longitudinal cohort study.

K. Ruxrungtham, A. Chutinet, J. Sophonphan, 2021, AIDS research and human retroviruses.

Decades research and implementation science of HIV prevention, treatment and cure: highlights from Symposium 2017

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2017 .

Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ ritonavir, in pretreated children at 96 weeks

J. Ananworanich, K. Ruxrungtham, T. Puthanakit, 2009, Antiviral therapy.

Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting.

K. Ruxrungtham, W. Prasithsirikul, W. Manosuthi, 2010, AIDS research and human retroviruses.

Optimization of a Der p 2-based prophylactic DNA vaccine against house dust mite allergy.

K. Ruxrungtham, S. Sirivichayakul, E. Prompetchara, 2013, Immunology letters.

Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis

K. Ruxrungtham, M. Nelson, L. Lavreys, 2009, AIDS.

Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.

S. Lewin, K. Ruxrungtham, P. Price, 2009, The Journal of infectious diseases.

Strategies to improve the immunogenicity of prM+E dengue virus type-2 DNA vaccine.

E. Konishi, K. Ruxrungtham, E. Prompetchara, 2016, Asian Pacific journal of allergy and immunology.

Large transmission cluster of acute hepatitis C identified among HIV‐positive men who have sex with men in Bangkok, Thailand

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2020, Liver international : official journal of the International Association for the Study of the Liver.

No effect of interleukin-2 on IgE levels given in addition to antiretroviral therapy in HIV-infected adults with CD4 >300 cells/mm3.

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2005, Asian Pacific journal of allergy and immunology.

Dyslipidemia in an Asian Population After Treatment for Two Years With Protease Inhibitor-Containing Regimens

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2007, Journal of the International Association of Physicians in AIDS Care.

Cost savings by reagent reduction in flow cytometry-based CD4+ T cell counts: an approach to improve accessibility for HIV management.

K. Ruxrungtham, S. Sirivichayakul, P. Phanuphak, 2007, Asian Pacific journal of allergy and immunology.

A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays.

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2012, Tuberculosis.

Impact of particulate air pollutants on allergic diseases, allergic skin reactivity and lung function.

K. Ruxrungtham, P. Thampanitchawong, J. Klaewsongkram, 2002, Asian Pacific journal of allergy and immunology.

Genetic Barrier to the Development of Resistance to Integrase Inhibitors in HIV-1 Subtypes CRF01_AE and B

C. Delaugerre, K. Ruxrungtham, H. Nguyen, 2012, Intervirology.

Chronic hepatitis C infection and liver disease in HIV co-infected patients in Asia

K. Ruxrungtham, M. Law, A. Sohn, 2017 .

PHARMACOKINETICS OF ATAZANAVIR IN RITONAVIR-BOOSTED COMBINATION IN ASIAN HEALTHY VOLUNTEERS: COMPARISONS BETWEEN THE STANDARD AND REDUCED DOSES OF BOTH AGENTS

K. Ruxrungtham, D. Panomvana, Chankit Puttilerpong, 2013 .

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

T. Griffin, R. Dewar, J. Metcalf, 2017, Open forum infectious diseases.

AIDS at a university hospital in Bangkok, Thailand.

K. Ruxrungtham, S. Sirivichayakul, P. Phanuphak, 1996, AIDS (London).

A Randomized, Open‐Label, Comparative Trial of Zidovudine Plus Lamivudine Versus Zidovudine Plus Lamivudine Plus Didanosine in Antiretroviral‐Naive HIV‐1‐Infected Thai Patients

S. Suwanagool, K. Ruxrungtham, D. Cooper, 2001, Journal of acquired immune deficiency syndromes.

Update on HIV/AIDS in Thailand.

K. Ruxrungtham, P. Phanuphak, 2001, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children

R. Paul, J. Ananworanich, K. Ruxrungtham, 2015, Journal of virus eradication.

Eosinophil Count in Nasal Mucosa Is More Suitable than the Number of ICAM-1-Positive Nasal Epithelial Cells to Evaluate the Severity of House Dust Mite-Sensitive Allergic Rhinitis: A Clinical Correlation Study

K. Ruxrungtham, J. Klaewsongkram, P. Wannakrairot, 2003, International Archives of Allergy and Immunology.

XXIV World Allergy Congress 2015

Dong Hun Lee, Young Han Kim, Byung Soo Kim, 2016, The World Allergy Organization Journal.

CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV

K. Ruxrungtham, S. Kerr, S. Gatechompol, 2018, AIDS Research and Therapy.

Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis.

K. Ruxrungtham, W. Prasithsirikul, W. Manosuthi, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.

K. Ruxrungtham, S. Rattanasiri, W. Prasithsirikul, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk

G. Bloomfield, C. Fichtenbaum, K. Ruxrungtham, 2022, AIDS.

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.

K. Ruxrungtham, J. Klaewsongkram, P. Rerknimitr, 2016, Allergology international : official journal of the Japanese Society of Allergology.

A Randomized Trial Comparing Plasma Drug Concentrations and Efﬁcacies between 2 Nonnucleoside Reverse-Transcriptase Inhibitor–Based Regimens in HIV-Infected Patients Receiving Rifampicin: The N 2 R Study

K. Ruxrungtham, W. Manosuthi, S. Sungkanuparph, 2009 .

Sensitivity and specificity of anti-double-stranded RNA immunofluorescence for universal detection of viral infection in respiratory specimens

K. Ruxrungtham, S. Kerr, V. Nilaratanakul, 2021, Heliyon.

Sexual risk behaviour reduction associated with voluntary HIV counselling and testing in HIV infected patients in Thailand.

O. Müller, K. Ruxrungtham, P. Phanuphak, 1995, AIDS care.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Thermoresponsive Bacteriophage Nanocarrier as a Gene Delivery Vector Targeted to the Gastrointestinal Tract

K. Ruxrungtham, A. Hajitou, S. Puttipipatkhachorn, 2018, Molecular therapy. Nucleic acids.

Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus.

S. Lewin, K. Ruxrungtham, C. Thio, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The pharmacokinetics, safety and efficacy of boosted saquinavir tablets in HIV type-1-infected pregnant women

D. Hawkins, K. Ruxrungtham, M. Vogel, 2008, Antiviral therapy.

Pharmacokinetics of nucleoside/nucleotide reverse transcriptase inhibitors for the treatment and prevention of HIV infection

K. Ruxrungtham, S. Kerr, S. Jianmongkol, 2020, Expert opinion on drug metabolism & toxicology.

Life Expectancy after Initiation of Combination Antiretroviral Therapy in Thailand

K. Ruxrungtham, S. Kerr, M. Law, 2017, Antiviral therapy.

Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2020, PloS one.

Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults.

K. Ruxrungtham, J. Sophonphan, S. Gatechompol, 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy.

B. Hirschel, J. Ananworanich, R. Nuesch, 2008, The Journal of antimicrobial chemotherapy.

A Prospective Study of Efficacy and Safety of Once-Daily Saquinavir/Ritonavir plus Two Nucleoside Reverse Transcriptase Inhibitors in Treatment-Naive Thai Patients

B. Hirschel, J. Ananworanich, R. Nuesch, 2005, Antiviral therapy.

IL-10-producing innate lymphoid cells increased in house-dust-mite allergic rhinitis patients following immunotherapy.

K. Ruxrungtham, S. Sirivichayakul, P. Chatchatee, 2020, The Journal of allergy and clinical immunology.

Safety and immunogenicity of a prefusion non-stabilized spike protein mRNA COVID-19 vaccine: a phase I trial

D. Weissman, K. Ruxrungtham, S. Kerr, 2022, Nature Microbiology.

Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm3 in Thailand☆

P. Hansasuta, J. Ananworanich, K. Ruxrungtham, 2020, Journal of virus eradication.

Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis

K. Ruxrungtham, S. Kerr, J. Amin, 2017, HIV medicine.

Cognitive Function and Neurodevelopmental Outcomes in HIV-infected Children Older Than 1 Year of Age Randomized to Early Versus Deferred Antiretroviral Therapy: The PREDICT Neurodevelopmental Study

R. Paul, J. Ananworanich, K. Ruxrungtham, 2013, The Pediatric infectious disease journal.

Bone health and HIV in resource-limited settings: a scoping review

K. Ruxrungtham, F. Matovu, J. Pettifor, 2016, Current opinion in HIV and AIDS.

Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings

K. Ruxrungtham, R. Gross, S. Kerr, 2021, AIDS.

Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients

K. Ruxrungtham, S. Kerr, N. Singkham, 2016, Expert review of clinical pharmacology.

Clinical practice guideline for diagnosis and management of urticaria.

K. Ruxrungtham, S. Benjaponpitak, P. Chatchatee, 2016, Asian Pacific journal of allergy and immunology.

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand

K. Ruxrungtham, P. Phanuphak, M. Leechawengwongs, 2015, AIDS Research and Therapy.

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

B. Gazzard, C. Katlama, K. Ruxrungtham, 2004, The Lancet.

Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin

A. Vibhagool, K. Ruxrungtham, S. Rattanasiri, 2005, AIDS.

Boosted versus Unboosted Indinavir with Zidovudine and Lamivudine in Nucleoside Pre-Treated Patients: A Randomized, Open-Label Trial with 112 Weeks of Follow-Up (HIV-Nat 005)

K. Ruxrungtham, D. Cooper, P. Reiss, 2006, Antiviral therapy.

Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2008, AIDS.

Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance

S. Lewin, K. Ruxrungtham, P. Angus, 2008, Hepatology.

Treatment of HIV infection with once-daily regimens

K. Ruxrungtham, A. Avihingsanon, N. Permpalung, 2012, Expert opinion on pharmacotherapy.

HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing.

S. Lewin, K. Ruxrungtham, C. Thio, 2010, Virology.

CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial

Matthias Cavassini, Urs Karrer, Hansjakob Furrer, 2006, The Lancet.

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2004, AIDS.

Pharmacokinetics of Stavudine and Didanosine Coadministered with Nelfinavir in Human Immunodeficiency Virus-Exposed Neonates

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2001, Antimicrobial Agents and Chemotherapy.

UvA-DARE ( Digital Academic Repository ) A prospective , randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2005 .

Characterization of hepatitis B virus mutations in untreated patients co‐infected with HIV and HBV based on complete genome sequencing

K. Ruxrungtham, P. Tangkijvanich, Y. Poovorawan, 2013, Journal of medical virology.

No Increase in Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Patients with HIV-1-HBV Coinfections following HBV-Active Highly Active Antiretroviral Therapy

S. Lewin, K. Ruxrungtham, S. Sirivichayakul, 2010, Journal of Virology.

Impaired Quality of the Hepatitis B Virus (HBV)-Specific T-Cell Response in Human Immunodeficiency Virus Type 1-HBV Coinfection

S. Lewin, K. Ruxrungtham, D. Cooper, 2009, Journal of Virology.

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial

B. Clotet, K. Ruxrungtham, M. Johnson, 2011, The Lancet.

Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.

J. Ananworanich, K. Ruxrungtham, L. Ferradini, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence and risk factors for nevirapine related toxicities among HIV-infected Asian children randomized to starting ART at different CD4%

K. Ruxrungtham, T. Puthanakit, S. Kanjanavanit, 2011 .

A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.

K. Ruxrungtham, W. Manosuthi, S. Sungkanuparph, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics and 48-Week Efficacy of Nevirapine: 400 mg Versus 600 mg per day in HIV–Tuberculosis Coinfection Receiving Rifampicin

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2008, Antiviral therapy.

HIV drug resistance transmission threshold survey in Bangkok, Thailand

K. Ruxrungtham, S. Sirivichayakul, P. Phanuphak, 2008, Antiviral therapy.

Pharmacokinetics of once-daily saquinavir hard-gelatin capsules and saquinavir soft-gelatin capsules boosted with ritonavir in HIV-1-infected subjects.

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2003, Journal of acquired immune deficiency syndromes.

The 48‐week efficacy of once‐daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2005, HIV medicine.

Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily.

B. Hirschel, K. Ruxrungtham, D. Cooper, 2004, The Journal of antimicrobial chemotherapy.

Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients.

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2005, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients.

K. Ruxrungtham, D. Cooper, P. Reiss, 2003, The Journal of antimicrobial chemotherapy.

Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates

K. Ruxrungtham, S. Malaivijitnond, W. Wijagkanalan, 2021, Frontiers in Plant Science.

Double Boosted Protease Inhibitors, Saquinavir, and Lopinavir/Ritonavir, in Nucleoside Pretreated Children at 48 Weeks

J. Ananworanich, K. Ruxrungtham, T. Bunupuradah, 2008, The Pediatric infectious disease journal.

Potent activity of 2'-beta-fluoro-2',3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice

R. Davey, H. Lane, K. Ruxrungtham, 1996, Antimicrobial agents and chemotherapy.

Factors Associated with Elevated ALT in an International HIV/HBV Co-Infected Cohort on Long-Term HAART

S. Lewin, K. Ruxrungtham, C. Thio, 2011, PloS one.

Influence of ABCC2 and ABCC4 Polymorphisms on Tenofovir Plasma Concentrations in Thai HIV-Infected Patients

K. Ruxrungtham, A. Avihingsanon, D. Burger, 2015, Antimicrobial Agents and Chemotherapy.

Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients

Beatriz Grinsztejn, K. Ruxrungtham, P. Cahn, 2011, AIDS.

Efficacy and improvement of lipid profile after switching to rilpivirine in resource limited setting: real life clinical practice

K. Ruxrungtham, S. Kerr, S. Gatechompol, 2019, AIDS Research and Therapy.

Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial.

K. Ruxrungtham, A. Pozniak, B. Grinsztejn, 2011, AIDS research and human retroviruses.

In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy.

J. Ananworanich, R. Nuesch, K. Ruxrungtham, 2003, Journal of acquired immune deficiency syndromes.

Plasma Tenofovir Concentrations and Proximal Tubular Dysfunction in HIV-Infected Adults Receiving Tenofovir in Thailand

K. Ruxrungtham, Y. Avihingsanon, J. Sophonphan, 2015 .

Loss to follow-up and Associated Factors of Patients in the National AIDS Program in Thailand

K. Ruxrungtham, S. Kerr, M. Law, 2018, Antiviral therapy.

The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000–2014

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2017, Journal of virus eradication.

Hidden Drug Resistant HIV to Emerge in the Era of Universal Treatment Access in Southeast Asia

Praphan Phanuphak, Jintanat Ananworanich, Stephen J. Kerr, 2010, PloS one.

Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010

Praphan Phanuphak, Somnuek Sungkanuparph, K. Ruxrungtham, 2010 .

Predictors of CD4 count change over 8 months of follow up in HIV‐1‐infected patients with a CD4 count≥300 cells/μL who were assigned to 7.5 MIU interleukin‐2

B. Gazzard, F. Antunes, Z. Fox, 2007, HIV medicine.

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

Huldrych F. Günthard, Tulio de Oliveira, Lynn Morris, 2016 .

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.

Somnuek Sungkanuparph, Khuanchai Supparatpinyo, S. Suwanagool, 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus‐1–hepatitis B virus coinfected individuals: Similar effectiveness of lamivudine, tenofovir, or combination therapy

A. Perelson, S. Lewin, K. Ruxrungtham, 2009, Hepatology.

Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses.

S. Lewin, K. Ruxrungtham, D. Boulware, 2013, The Journal of infectious diseases.

Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.

K. Ruxrungtham, U. Thisyakorn, P. Thaithumyanon, 2002, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Low Dose Lopinavir/Ritonavir Tablet Achieves Adequate Pharmacokinetic Parameters in HIV-Infected Thai Adolescents

J. Ananworanich, K. Ruxrungtham, S. Kerr, 2012, Antiviral therapy.

A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2012, Antiviral therapy.

Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals

S. Lewin, K. Ruxrungtham, G. Dore, 2013, PloS one.

HIV/AIDS in Asia

T. Brown, K. Ruxrungtham, P. Phanuphak, 2003, The Lancet.

Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children.

J. Ananworanich, K. Ruxrungtham, T. Puthanakit, 2009, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults.

K. Ruxrungtham, D. Cooper, R. Autar, 2008, The Journal of antimicrobial chemotherapy.

Long-Term Efficacy and Safety of First-Line Therapy with Once-Daily Saquinavir/Ritonavir

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2007, Antiviral therapy.

Pharmacokinetics and 24-Week Efficacy/Safety of Dual Boosted Saquinavir/Lopinavir/Ritonavir in Nucleoside-Pretreated Children

J. Ananworanich, K. Ruxrungtham, U. Siangphoe, 2005, The Pediatric infectious disease journal.

Pharmacokinetics of Reduced-Dose Indinavir/Ritonavir 400/100 Mg Twice Daily in HIV-1-Infected Thai Patients

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2005, Antiviral therapy.

Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries

K. Ruxrungtham, A. Hill, D. Burger, 2010, Current opinion in HIV and AIDS.

A Low Dose of Ritonavir‐Boosted Atazanavir Provides Adequate Pharmacokinetic Parameters in HIV‐1‐Infected Thai Adults

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2009, Clinical pharmacology and therapeutics.

Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: a pilot study.

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2012, AIDS research and human retroviruses.

Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Handan Wand, Sean Emery, Daniel E Nixon, 2011, The Journal of infectious diseases.

High proportion of blood-borne and sexually transmitted infections among people deprived of liberty in a central male prison in Thailand: a cross-sectional study 2018-2019.

K. Ruxrungtham, P. Phanuphak, P. Tangkijvanich, 2022, AIDS research and human retroviruses.

Chronic hepatitis C infection and liver disease in HIV‐coinfected patients in Asia

K. Ruxrungtham, A. Sohn, M. Law, 2017, Journal of viral hepatitis.

Immunogenicity assay validation for an HIV vaccine trial: high IFNγ+/IL-2+ CD8+ T cells background in healthy Thais.

K. Ruxrungtham, S. Sirivichayakul, A. Kelleher, 2011, Vaccine.

An HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase I/IIa trial in Thai volunteers at low risk of HIV infection

K. Ruxrungtham, D. Cooper, S. Sirivichayakul, 2010, Human vaccines.

Development of a point-of-care test to detect hepatitis B virus DNA threshold relevant for treatment indication

K. Ruxrungtham, J. Kampeera, W. Kiatpathomchai, 2018, Asian Biomedicine.

Nevirapine Plasma Concentrations and Concomitant Use of Rifampin in Patients Coinfected with HIV-1 and Tuberculosis

K. Ruxrungtham, D. Cooper, R. Autar, 2005, Antiviral therapy.

Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment

C. Katlama, J. Gatell, V. Soriano, 2007, Expert opinion on pharmacotherapy.

Pharmacogenetic testing can identify patients taking atazanavir at risk for hyperbilirubinemia.

K. Ruxrungtham, S. Kerr, K. Suphapeetiporn, 2015, Journal of acquired immune deficiency syndromes.

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

B. Autran, J. Ananworanich, K. Ruxrungtham, 2009, AIDS.

Simplifying Protease Inhibitor Therapy with Once‐Daily Dosing of Saquinavir Soft‐Gelatin Capsules/Ritonavir (1600/100 mg): HIVNAT 001.3 Study

K. Ruxrungtham, D. Cooper, J. Beijnen, 2002, Journal of acquired immune deficiency syndromes.

Impact of Baseline Virologic, Immunologic, and Demographic Characteristics on Virologic Responses in the Gemini Study

K. Ruxrungtham, S. Walmsley, A. Avihingsanon, 2012, HIV clinical trials.

A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001)

K. Ruxrungtham, D. Cooper, S. Sirivichayakul, 2000 .

Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment

K. Ruxrungtham, P. Phanuphak, M. Law, 2007, HIV medicine.

Pharmacokinetics of Lower Doses of Saquinavir Soft-Gel Caps (800 and 1200 Mg Twice Daily) Boosted with Itraconazole in HIV-1-Positive Patients

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2002, Antiviral therapy.

Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir

K. Ruxrungtham, D. Cooper, J. Miners, 2006, Pharmacogenetics and genomics.

Pharmacokinetics of Indinavir/Ritonavir (800/100 mg) in Combination With Efavirenz (600 mg) in HIV‐1‐Infected Subjects

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2003, Journal of acquired immune deficiency syndromes.

Low-Dose Ritonavir-Boosted Atazanavir (200/100 mg) Maintained a High Virological Efficacy Up To 4 Years in Treatment-Experienced HIV-1 Infected Adults: A Prospective Cohort Study from Asia

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2015 .

Pharmacokinetics of and Short-Term Virologic Response to Low-Dose 400-Milligram Once-Daily Raltegravir Maintenance Therapy

J. Ananworanich, K. Ruxrungtham, S. Kerr, 2012, Antimicrobial Agents and Chemotherapy.

Neither Branded Nor Generic Lopinavir/Ritonavir Produces Adequate Lopinavir Concentrations at a Reduced Dose of 200/50 mg Twice Daily

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2012, Journal of acquired immune deficiency syndromes.

Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2009, Antiviral therapy.

Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates.

K. Ruxrungtham, S. Pichyangkul, A. Engering, 2008, Veterinary immunology and immunopathology.

Interferon gamma for diagnosing tuberculous pleural effusions

K. Ruxrungtham, U. Silachamroon, V. Udompanich, 1999, Thorax.

IL-1beta, IL-6 and TNF-alpha in synovial fluid of patients with non-gonococcal septic arthritis.

K. Ruxrungtham, M. Osiri, Y. Ohmoto, 1998, Asian Pacific journal of allergy and immunology.

Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand.

J. Ananworanich, R. Nuesch, K. Ruxrungtham, 2006, The Journal of antimicrobial chemotherapy.

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

K. Ruxrungtham, D. Berger, M. D. Béthune, 2007, The Lancet.

Increased interleukin-17 production both in helper T cell subset Th17 and CD4-negative T cells in human immunodeficiency virus infection.

K. Ruxrungtham, J. Klaewsongkram, W. Maek-a-nantawat, 2007, Viral immunology.

Phylogenetic analysis of HIV-1 shows frequent cross-country transmission and local population expansions

K. Ruxrungtham, J. Lundgren, M. Worobey, 2021, Virus evolution.

Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1.

K. Ruxrungtham, P. Phanuphak, P. Phanuphak, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of anemia and underlying iron status in naive antiretroviral therapy HIV-infected children with moderate immune suppression.

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2012, AIDS research and human retroviruses.

The linkage of allergic rhinitis and obstructive sleep apnea.

K. Ruxrungtham, N. Chirakalwasan, 2014, Asian Pacific journal of allergy and immunology.

Novel Criteria for Diagnosing Acute and Early HIV Infection in a Multi-National Study of Early Antiretroviral Therapy Initiation.

B. Chi, J. Ananworanich, K. Ruxrungtham, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Minority HIV‐1 resistant variants in recent infection and in patients who failed first‐line antiretroviral therapy with no detectable resistance‐associated mutations in Thailand

C. Delaugerre, K. Ruxrungtham, S. Sirivichayakul, 2012, Journal of medical virology.

A Novel Immunodominant CD8+ T Cell Response Restricted by a Common HLA-C Allele Targets a Conserved Region of Gag HIV-1 Clade CRF01_AE Infected Thais

Praphan Phanuphak, Christian Brander, Todd M. Allen, 2011, PloS one.

Japan’s Collaboration with Thailand in the Development of an HIV/AIDS Vaccine

K. Ruxrungtham, N. Yamamoto, S. Yamazaki, 2004 .

Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses

J. Sodroski, B. Haynes, D. Kaufmann, 2017, Journal of Virology.

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children

J. Ananworanich, K. Ruxrungtham, W. Prasitsuebsai, 2011, AIDS research and therapy.

Attrition and Mortality of Children Receiving Antiretroviral Treatment through the Universal Coverage Health Program in Thailand

K. Ruxrungtham, S. Kerr, T. Puthanakit, 2017, The Journal of pediatrics.

Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial.

R. Paul, J. Ananworanich, K. Ruxrungtham, 2012, The Lancet. Infectious diseases.

Impact of antiretroviral therapy on quality of life in HIV-infected Southeast Asian children in the PREDICT study.

J. Ananworanich, K. Ruxrungtham, T. Puthanakit, 2013, AIDS Patients Care and STDs.

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.

D. Katzenstein, N. Ford, R. Shafer, 2013, The Journal of infectious diseases.

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.

K. Ruxrungtham, D. Cooper, H. Teppler, 2015, The lancet. HIV.

Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults

D. Ward, K. Ruxrungtham, S. Walmsley, 2009, Journal of acquired immune deficiency syndromes.

First line antiretroviral treatment outcomes and durability in HIV-infectedchildren treatedthrough theuniversal coverage health program in Thailand.

K. Ruxrungtham, S. Kerr, T. Puthanakit, 2017, Journal of acquired immune deficiency syndromes.

Immune responses to measles immunization and the impacts on HIV-infected children.

K. Ruxrungtham, U. Thisyakorn, P. Thaithumyanon, 2000, The Southeast Asian journal of tropical medicine and public health.

Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in Thailand

K. Ruxrungtham, S. Kerr, G. Suwanpimolkul, 2019, Journal of virus eradication.

Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors.

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Attrition and treatment outcomes among adolescents and youths living with HIV in the Thai National AIDS Program

K. Ruxrungtham, S. Kerr, T. Puthanakit, 2019, Journal of virus eradication.

HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2005, AIDS.

Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.

K. Ruxrungtham, A. Phillips, S. Sirivichayakul, 1998, International journal of epidemiology.

Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2008, International journal of STD & AIDS.

Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2011, AIDS.

Changing evidence on HIV treatment and prevention strategies: implications and advice for healthcare workers and National Treatment Programs in Asia

J. Ananworanich, K. Ruxrungtham, S. Kerr, 2010 .

Clinical perspectives on human genetic screening to prevent nevirapine toxicity.

D. Podzamczer, K. Ruxrungtham, D. Haas, 2012, Personalized medicine.

Interleukin-1 BLevel in Gingival Crevicu lar Fluid of Patients with Active Perio dontitis

K. Ruxrungtham, Y. Ohmoto, P. Laohapand, 2000 .

Rationale and clinical utility of the darunavir–cobicistat combination in the treatment of HIV/AIDS

K. Ruxrungtham, A. Avihingsanon, O. Putcharoen, 2015, Drug design, development and therapy.

Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity Implications for HIV Transmission

K. Ruxrungtham, R. Center, S. Kent, 2016, Journal of acquired immune deficiency syndromes.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients.

K. Ruxrungtham, P. Phanuphak, N. Suwanwela, 2000, Magnetic resonance imaging.

Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients

K. Ruxrungtham, P. Phanuphak, S. Eiam‐Ong, 2012, AIDS.

CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studies.

R. Davey, H. Lane, K. Ruxrungtham, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation

M. Maes, M. Geffard, A. Carvalho, 2017, Molecular Neurobiology.

Dengue vaccine: Global development update.

K. Ruxrungtham, Stephen J. Thomas, E. Prompetchara, 2019, Asian Pacific journal of allergy and immunology.

Induction of Neutralizing Antibody Response against Four Dengue Viruses in Mice by Intramuscular Electroporation of Tetravalent DNA Vaccines

K. Ruxrungtham, E. Prompetchara, C. Ketloy, 2014, PloS one.

Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma

K. Ruxrungtham, H. Chantaphakul, 2016, Expert opinion on pharmacotherapy.

Three suitable antigens for delayed-type hypersensitivity skin testing in a tropical country like Thailand.

K. Ruxrungtham, K. Siripassorn, P. Charoenwongse, 2005, Asian Pacific journal of allergy and immunology.

Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid

M. Geffard, A. Carvalho, K. Ruxrungtham, 2017, Molecular Neurobiology.

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2005, Journal of Acquired Immune Deficiency Syndromes.

COVID-19 and HIV infection co-pandemics and their impact: a review of the literature

D. Kuritzkes, K. Ruxrungtham, S. Gatechompol, 2021, AIDS Research and Therapy.

Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study – PEDA Study

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2016, PloS one.

The Impact of Combination Antiretroviral Therapy and its Interruption on Anxiety, Stress, Depression and Quality of Life in Thai Patients

B. Hirschel, K. Ruxrungtham, A. Gayet-Ageron, 2009, The open AIDS journal.

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT

K. Ruxrungtham, A. Kelleher, M. Karyana, 2022, HIV research & clinical practice.

Transmitted HIV drug resistance at the Thai Red Cross anonymous clinic in Bangkok: results from three consecutive years of annual surveillance.

K. Ruxrungtham, S. Sirivichayakul, P. Phanuphak, 2014, The Journal of antimicrobial chemotherapy.

Long‐term outcomes of rapid antiretroviral NNRTI‐based initiation among Thai youth living with HIV: a national registry database study

K. Ruxrungtham, S. Kerr, T. Puthanakit, 2023, Journal of the International AIDS Society.

Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors.

Jerome H. Kim, K. Ruxrungtham, S. Sirivichayakul, 2012, AIDS research and human retroviruses.

Evidence of three HIV-1 subtypes in subgroups of individuals in Thailand

K. Ruxrungtham, S. Sirivichayakul, P. Phanuphak, 1994, The Lancet.

A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2000, AIDS.

Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia

S. Hemrungrojn, M. Maes, M. Geffard, 2017, Molecular Neurobiology.

Translating a Thin-Film Rehydration Method to Microfluidics for the Preparation of a SARS-CoV-2 DNA Vaccine: When Manufacturing Method Matters

K. Ruxrungtham, A. Neels, G. Borchard, 2022, Pharmaceutics.

Dose‐Escalating Study of the Safety and Pharmacokinetics of Nelfinavir in HIV‐Exposed Neonates

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2002, Journal of acquired immune deficiency syndromes.

CXCL-10, Interleukin-12 and Interleukin-21 are not Immunological Predictors of Hbeag Seroconversion in HIV-1–HBV Coinfection following HBV-Active Antiretroviral Therapy

S. Lewin, K. Ruxrungtham, J. Sasadeusz, 2014, Antiviral therapy.

after endotoxin challenge in humans Gene expression profiles of peripheral blood leukocytes

P. Munson, S. Lewin, J. Brenchley, 2011 .

The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs

H. Rees, K. Ruxrungtham, P. Olliaro, 2023, Vaccines.

Recurring thrombocytopenia associated with structured treatment interruption in patients with human immunodeficiency virus infection.

J. Ananworanich, R. Nuesch, K. Ruxrungtham, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Successful drug desensitization in patients with delayed-type allergic reactions to anti-tuberculosis drugs.

K. Ruxrungtham, W. Manosuthi, K. Siripassorn, 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes

K. Ruxrungtham, S. Kerr, Supalak Phonphithak, 2017, AIDS.

Genital shedding of HIV after scheduled treatment interruption

P. Vernazza, B. Hirschel, J. Ananworanich, 2011, International journal of STD & AIDS.

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial

K. Ruxrungtham, D. Cooper, F. Bergmann, 2016, PloS one.

Alemtuzumab-induced elimination of HIV-1-infected immune cells

K. Ruxrungtham, S. Sirivichayakul, S. Buranapraditkun, 2016, Journal of virus eradication.

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

R. Schooley, R. Dewar, J. Metcalf, 2019, The Lancet. Respiratory medicine.

Absence of Resistance Mutations in Antiretroviral-Naive Patients Treated with Ritonavir-Boosted Saquinavir

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2005, Antiviral therapy.

Continuous ambulatory peritoneal dialysis improves both the number and memory function of CD4 T cells in uremic patients.

K. Ruxrungtham, S. Eiam‐Ong, T. Kansanabuch, 2004, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Sleep Quality of Hospitalized Patients, Contributing Factors, and Prevalence of Associated Disorders

K. Ruxrungtham, S. Gonlachanvit, S. Reutrakul, 2020, Sleep disorders.

The minor house dust mite allergen Der p 13 is a fatty acid‐binding protein and an activator of a TLR2‐mediated innate immune response

K. Ruxrungtham, D. Gilis, P. Chatchatee, 2016, Allergy.

HIV-1 Genital Shedding in HIV-Infected Patients Randomized to Second-Line Lopinavir/Ritonavir Monotherapy versus Tenofovir/Lamivudine/Lopinavir/ Ritonavir

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2014, Antiviral therapy.

An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients

K. Ruxrungtham, S. Kerr, O. Putcharoen, 2013, HIV/AIDS.

Rilpivirine in treatment-naive patients: what did we learn from the THRIVE and ECHO studies?

K. Ruxrungtham, O. Putcharoen, 2013 .

Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy

C. Akdis, K. Ruxrungtham, S. Sirivichayakul, 2019, Allergy.

Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults

K. Ruxrungtham, J. Sophonphan, S. Gatechompol, 2018, Antiviral therapy.

Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.

J. Ananworanich, R. Nuesch, K. Ruxrungtham, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir.

K. Ruxrungtham, W. Prasithsirikul, W. Manosuthi, 2008, Journal of acquired immune deficiency syndromes.

Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV‐infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors

K. Ruxrungtham, P. Mootsikapun, P. Chetchotisakd, 2007, HIV medicine.

Alkali-treated penicillin G solution is a better option than penicillin G as an alternative source of minor determinants for penicillin skin test.

K. Ruxrungtham, J. Klaewsongkram, S. Buranapraditkun, 2012, Allergy and Asthma Proceedings.

Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV‐infected Thais

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2011, HIV medicine.

Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2012, Journal of NeuroVirology.

Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus—infected Thais from the 2NN Cohort Study

R. Paul, J. Ananworanich, K. Ruxrungtham, 2010, Journal of NeuroVirology.

Decline in Serum 25 Hydroxyvitamin D Levels in HIV–Hbv-Coinfected Patients after Long-Term Antiretroviral Therapy

S. Lewin, J. Ananworanich, K. Ruxrungtham, 2014, Antiviral therapy.

Creation of a drug fund for post-clinical trial access to antiretrovirals

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2004, The Lancet.

HIV-NAT Promoting Rational and Evidence-based Use of Antiretroviral Therapies

K. Ruxrungtham, D. Cooper, S. Kerr, 2006 .

Promoting Rational and Evidence-based Use of Antiretroviral Therapies HIV-NAT

K. Ruxrungtham, D. Cooper, S. Kerr, 2006 .

Efficacy and tolerability of zidovudine 200 mg twice a day as part of combination antiretroviral therapy for 96 weeks.

K. Ruxrungtham, P. Phanuphak, C. Duncombe, 2010, Journal of acquired immune deficiency syndromes.

A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients.

S. Suwanagool, K. Ruxrungtham, D. Cooper, 2001 .

A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia.

S. Hammer, M. Hughes, S. Suwanagool, 2000, Australian and New Zealand journal of medicine.

Ferritin levels during structured treatment interruption of highly active antiretroviral therapy

B. Hirschel, K. Ruxrungtham, C. Duncombe, 2007, HIV medicine.

A novel flavanone derivative inhibits dengue virus fusion and infectivity

K. Ruxrungtham, T. Rungrotmongkol, P. Phuwapraisirisan, 2018, Antiviral research.

Prevalence and risk of residual viremia after ART in low- and middle-income countries

J. Lifson, K. Ruxrungtham, S. Kerr, 2021, Medicine.

Characterization of the house dust mite allergen Der p 21 produced in Pichia pastoris.

K. Ruxrungtham, E. Nony, M. Le Mignon, 2014, Protein expression and purification.

Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.

K. Ruxrungtham, G. Suwanpimolkul, K. Kawkitinarong, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High Rate Multiple Drug Resistances in HIV-Infected Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Thailand, Where Subtype A/E is Predominant

K. Ruxrungtham, P. Chetchotisakd, S. Kiertiburanakul, 2006, Journal of the International Association of Physicians in AIDS Care.

Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2008, The open virology journal.

Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice

D. Weissman, K. Ruxrungtham, J. Heyes, 2023, Nature communications.

Comparison of immunological characteristics of peripheral, splenic and tonsilar naïve B cells by differential gene expression meta-analyses.

C. Nguyen, K. Ruxrungtham, L. Grieco, 2012, Asian Pacific journal of allergy and immunology.

Body Weight Cutoff for Daily Dosage of Efavirenz and 60-Week Efficacy of Efavirenz-Based Regimen in Human Immunodeficiency Virus and Tuberculosis Coinfected Patients Receiving Rifampin

K. Ruxrungtham, W. Manosuthi, S. Sungkanuparph, 2009, Antimicrobial Agents and Chemotherapy.

Etravirine and Rilpivirine Resistance in HIV-1 Subtype Crf01_Ae-Infected Adults Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2011, Antiviral therapy.

Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor‐naïve, nonnucleoside reverse transcriptase inhibitor‐experienced patients: study TMC125‐C227 *

K. Ruxrungtham, M. Peeters, J. Vingerhoets, 2008, HIV medicine.

Lessons from a multicentre paediatric HIV trial

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2008, The Lancet.

The 15th Bangkok international symposium on HIV medicine.

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2009 .

Impact of early antiretroviral treatment on sexual behaviour: a randomised comparison

J. Gatell, K. Ruxrungtham, A. Phillips, 2019, AIDS (London).

Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok

J. Kaldor, J. Ananworanich, K. Ruxrungtham, 2012, The open virology journal.

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study

K. Ruxrungtham, F. Struyf, G. Dubin, 2020, EClinicalMedicine.

LPS , immune activation and liver abnormalities in HIV-HBV co-infected individuals on HBV-active combination antiretroviral therapy

Doré, Pushparaj, S. Lewin, 2014 .

Advanced liver fibrosis by transient elastography, Fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: Role of vitamin D levels

K. Ruxrungtham, P. Tangkijvanich, Y. Poovorawan, 2014, Journal of gastroenterology and hepatology.

Longitudinal analysis of integrase N155H variants in heavily treated patients failing raltegravir‐based regimens

C. Charpentier, C. Delaugerre, K. Ruxrungtham, 2013, HIV medicine.

Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients.

K. Ruxrungtham, C. Sukasem, A. Avihingsanon, 2017, Pharmacogenomics.

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

Henrik Nielsen, L. Mathiesen, C. Leen, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High-Sensitivity Troponins and Subclinical Coronary Atherosclerosis Evaluated by Coronary Calcium Score Among Older Asians Living With Well-Controlled Human Immunodeficiency Virus

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2023, Open forum infectious diseases.

Impact of early antiretroviral treatment on sexual behaviour: a randomised comparison

J. Gatell, K. Ruxrungtham, A. Phillips, 2019, AIDS.

Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody

K. Ruxrungtham, G. Screaton, S. Yoksan, 2023, Microbiology spectrum.

Influence of ABCC 2 and ABCC 4 Polymorphisms on Tenofovir Plasma Concentrations in Thai HIV-Infected Patients

K. Ruxrungtham, A. Avihingsanon, D. Burger, 2017 .

Inﬂuence of ABCC2 and ABCC4 Polymorphisms on Tenofovir Plasma Concentrations in Thai HIV-Infected Patients

K. Ruxrungtham, A. Avihingsanon, D. Burger, 2015 .

Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway

M. Geffard, A. Carvalho, K. Ruxrungtham, 2017, Metabolic Brain Disease.

Significant differences between plasma HIV-1 RNA assays in HIV-1 subtype E infected patients treated with antiretroviral therapy.

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2002, Asian Pacific journal of allergy and immunology.

Non AIDS complications and treatment optimizations for HIV-1 infected Thai adult patients with and without TB or hepatitis

S. Lewin, K. Ruxrungtham, D. Cooper, 2013 .

Ending AIDS and challenges for Asia

K. Ruxrungtham, P. Phanuphak, W. Prasitsuebsai, 2015 .

A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand

S. Suwanagool, R. Davey, H. Lane, 2000, AIDS.

It is time for ambitious, transformational change to the epidemic countermeasures ecosystem

K. Ruxrungtham, S. Nishtar, H. Legido-Quigley, 2023, The Lancet.

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

Domenico Di Carlo, P. A. Bester, R. Shafer, 2022 .

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.

G. Gottlieb, J. Stringer, C. Yiannoutsos, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

CD4/CD8 Ratio Recovery of Children and Adolescents Living With HIV With Virological Suppression: A Prospective Cohort Study.

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2020, Journal of the Pediatric Infectious Diseases Society.

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

T. Harrer, A. Winston, E. Harrer, 2023, Scientific Reports.

Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy

K. Ruxrungtham, S. Kerr, G. Suwanpimolkul, 2022, Journal of the International AIDS Society.

Edinburgh Research Explorer Impact of early antiretroviral treatment on sexual behaviour in the INSIGHT Strategic Timing of Anti-Retroviral Treatment (START) Trial

J. Gatell, K. Ruxrungtham, A. Phillips, 2019 .

HIV medicine as double-sided sword: care and prevention

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2018 .

The roles of HIV-1 specific CD8+ T cell responses and HLA class I alleles on viral control and viral escape in HIV-1 infected Thai individuals

K. Ruxrungtham, S. Buranapraditkun, T. Allen, 2012, Retrovirology.

Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients.

S. Lewin, K. Ruxrungtham, A. Avihingsanon, 2015, International journal of clinical pharmacology and therapeutics.

Conference proceedings from hybrid 25th Bangkok International Symposium on HIV Medicine

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2023, Future Virology.

Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody

K. Ruxrungtham, G. Screaton, S. Yoksan, 2023, Microbiology spectrum.

Incident liver cirrhosis, associated factors and cardiovascular disease risks among people living with HIV: a longitudinal study.

K. Ruxrungtham, S. Kerr, P. Tangkijvanich, 2020, Journal of acquired immune deficiency syndromes.

Assessing adherence in Thai patients taking combination antiretroviral therapy

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2012, International journal of STD & AIDS.

The complex link of the environment on allergic rhinitis and atopic dermatitis.

K. Ruxrungtham, 2016, Asian Pacific journal of allergy and immunology.

The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.

K. Ruxrungtham, C. Ketloy, N. Sittisombut, 2015, Asian Pacific journal of allergy and immunology.

High-Sensitivity Troponins and Subclinical Coronary Atherosclerosis Evaluated by Coronary Calcium Score Among Older Asians Living With Well-Controlled Human Immunodeficiency Virus

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2023, Open forum infectious diseases.

Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure

K. Ruxrungtham, W. Prasithsirikul, W. Manosuthi, 2009, AIDS research and therapy.

K. Ruxrungtham, M. Peeters, J. Vingerhoets, 2008, HIV medicine.

Plasma levels of soluble CD14 independently predict mortality in HIV infection.

S. Lewin, D. Douek, J. Brenchley, 2011, The Journal of infectious diseases.

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

S. Lewin, K. Ruxrungtham, D. Cooper, 2008, Hepatology.

A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2012 .

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.

K. Ruxrungtham, D. Cooper, H. Teppler, 2015, The lancet. HIV.

A Randomized Double-Blind Phase 2 Study of Combination Antivirals for the Treatment of Influenza

M. Hughes, R. Schooley, R. Davey, 2017, The Lancet. Infectious diseases.

Detachable-dissolvable-microneedle as a potent subunit vaccine delivery device that requires no cold-chain

K. Ruxrungtham, T. Palaga, S. Wanichwecharungruang, 2023, Vaccine: X.

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.

S. Suwanagool, K. Ruxrungtham, M. Leechawengwongs, 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Resistance to dual nucleoside reverse-transcriptase inhibitors in children infected with HIV clade A/E.

J. Ananworanich, K. Ruxrungtham, S. Sirivichayakul, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors

Praphan Phanuphak, Joep Lange, Sean Emery, 2003, AIDS.

Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012).

A. Perelson, K. Ruxrungtham, D. Cooper, 2006, The Journal of infectious diseases.